Browse our latest news stories, media releases, publications and submissions.
Pancare Foundation Annual Review 2021
Pancare Foundation is proud to publish our Annual Review, highlighting our achievements of the 2020/21 financial year. Despite the ongoing COVID-19 pandemic presenting us with additional challenges, there is much to be proud of as we continue to accelerate change for upper gastrointestinal (GI) cancers.
Wins for pancreatic cancer clinical trials research
Pancare is delighted to have contributed to two successfully funded clinical trials for pancreatic cancer research, announced in the recent 2021 MRFF Rare Cancers and Unmet Need (RCRDUN) Clinical Trials initiative grant rounds.
Advent Security forge new partnership with Pancare Foundation
The tragic loss of a number of the Advent Security team’s close friends and family members to upper GI cancers resulted in the development of a formal partnership between Advent Security and Pancare Foundation driven by Michael Hill, Advent Security Business Manager, who has been personally impacted.
A message of thanks 2021 from CEO, Doug Hawkins
As we approach the end of another year disrupted by the COVID-19 pandemic, I reflect on what has been a resounding theme for our Foundation and community – resilience in the face of adversity.
Critical new cancer research grant announced
Pancare Foundation and Cancer Australia are pleased to announce successful applicants to the 2021 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS).
New grant gives hope to Australians living with rare cancer
Pancreatic and hepatobiliary surgeon, Dr Daniel Croagh has been awarded the Pancare Foundation-AGITG Cholangiocarcinoma Idea Generation Workshop Grant.
Coping with cancer during the holidays
For those impacted by cancer, experiences of the festive season can induce a range of feelings. Some people will enjoy a time of celebration, for others it may be a difficult time of stress and feelings of pressure and grief. We have put together a list of suggestions that may make the season less stressful.
Pancare Foundation Holiday Office Hours
We realise that the holidays can be a difficult time for many people, especially those impacted by an upper GI cancer. While our PanSupport team will be having a well-earned rest over the holiday period, please know that support is still available during this time for any crises or emergencies that may arise.
Recent study supports use of second line chemotherapy combined with active symptom control (ASC) for the treatment of advanced biliary tract cancer.
Patients with advanced biliary tract cancer receiving second-line FOLFOX chemotherapy and active symptom control (ASC) are more than twice as likely to be alive at 12 months compared to those on ASC alone, with a modest increase in treatment-related side effects.